How a global biopharma became a leader in ethical AI
EY teams used the global Responsible AI framework to help a biopharma optimize AI governance, mitigate AI risks and protect stakeholders.
A detailed independent review of AI governance
EY teams collaborated with the biopharma to review its approach to AI ethics using the global Responsible AI framework.
Driving responsible AI to reduce risk to stakeholders
EY teams helped the biopharma safeguard stakeholders, including the public, from AI ethical issues.
In challenging times, we’re #BetterTogether to build a better working world.
Through actions both big and small, our people are helping each other, clients and society tackle COVID-19 challenges and build an even better working world.